Home > Healthcare > Biotechnology > Biotechnology R&D > Exosomes Market

Exosomes Market Size

  • Report ID: GMI6862
  • Published Date: Oct 2023
  • Report Format: PDF

Exosomes Market size

Exosomes Market size was valued to be USD 250.8 million in 2022 and is expected to reach USD 3.2 billion in 2032 with a CAGR of 29.9% from 2023 to 2032. The market's significant growth is primarily driven by the rising cases of cancer worldwide.

 

The growing prevalence of cancer patients directly impacts the increased demand for exosomes, as they are used as cancer biomarkers for early detection and diagnosis. Also, increasing technological advancements in exosome isolation is a significant driving factor for the expansion of the exosome market. For instance, in November 2022, Cell Guidance Systems introduced its Instant Exosomes and LipoQ assay products. LipoQ is a lipid quantification test, and the Instant Exosomes are freeze-dried exosomes. They are used for assay calibration, protein marker analysis and as biomarkers in cancer diagnostics. Such advancements are anticipated to increase the use of exosomes for research and spur the industrial expansion.

 

Exosomes are small, membrane-bound vesicles that are secreted by various cell types, including both normal and pathological cells, such as cancer cells. They are a type of extracellular vesicle and are typically in the range of 30 to 150 nanometres in diameter. Exosomes play a crucial role in cell-to-cell communication by carrying a diverse cargo of bioactive molecules, including proteins, lipids, nucleic acids (such as RNA and DNA), and other biomolecules.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Exosomes industry size was USD 250.8 million in 2022 and is anticipated to expand at 29.9% CAGR from 2023 to 2032 driven by the rising cases of cancer worldwide.

The kits & reagents products & services segment accounted for 44.9% of the exosomes industry in 2022 and is set to witness high demand through 2032 owing to extensive usage by researchers in R&D activities and production of exosome-based drugs and therapies.

North America held 55.5% of the global exosomes market in 2022 and is projected to record robust growth through 2032 driven by presence of well-developed and advanced healthcare infrastructure.

Some of the leading companies operating in the exosomes industry include Thermo Fisher Scientific, Inc., Bio-Techne Corp., QIAGEN, Beckam Coulter (Danaher Corp), Diagenode (Hologic Inc), Lonza, Abcam, Fujifilm Holdings Corp., Hitachi Chemical Diagnostics Inc., and Clara Biotech.

Exosomes Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 314
  • Countries covered: 20
  • Pages: 170
 Download Free Sample